151 related articles for article (PubMed ID: 6320747)
21. Murine tumor cells expressing the gene for the human interferon alpha beta receptor elicit antibodies in syngeneic mice to the active form of the receptor.
Uzé G; Lutfalla G; Eid P; Maury C; Bandu MT; Gresser I; Mogensen K
Eur J Immunol; 1991 Feb; 21(2):447-51. PubMed ID: 1825636
[TBL] [Abstract][Full Text] [Related]
22. Mutational and structural analysis of the binding interface between type I interferons and their receptor Ifnar2.
Piehler J; Schreiber G
J Mol Biol; 1999 Nov; 294(1):223-37. PubMed ID: 10556041
[TBL] [Abstract][Full Text] [Related]
23. Evidence for glycosphingolipid modification of the type 1 IFN receptor.
Ghislain J; Lingwood CA; Fish EN
J Immunol; 1994 Oct; 153(8):3655-63. PubMed ID: 7930586
[TBL] [Abstract][Full Text] [Related]
24. Regulation of interferon receptor expression in human blood lymphocytes in vitro and during interferon therapy.
Lau AS; Hannigan GE; Freedman MH; Williams BR
J Clin Invest; 1986 May; 77(5):1632-8. PubMed ID: 3009549
[TBL] [Abstract][Full Text] [Related]
25. Design, characterization, and structure of a biologically active single-chain mutant of human IFN-gamma.
Landar A; Curry B; Parker MH; DiGiacomo R; Indelicato SR; Nagabhushan TL; Rizzi G; Walter MR
J Mol Biol; 2000 May; 299(1):169-79. PubMed ID: 10860730
[TBL] [Abstract][Full Text] [Related]
26. High-affinity binding sites for human 26-kDa protein (interleukin 6, B cell stimulatory factor-2, human hybridoma plasmacytoma growth factor, interferon-beta 2), different from those of type I interferon (alpha, beta), on lymphoblastoid cells.
Coulie PG; Vanhecke A; Van Damme J; Cayphas S; Poupart P; De Wit L; Content J
Eur J Immunol; 1987 Oct; 17(10):1435-40. PubMed ID: 3500055
[TBL] [Abstract][Full Text] [Related]
27. Determination of residues involved in ligand binding and signal transmission in the human IFN-alpha receptor 2.
Chuntharapai A; Gibbs V; Lu J; Ow A; Marsters S; Ashkenazi A; De Vos A; Jin Kim K
J Immunol; 1999 Jul; 163(2):766-73. PubMed ID: 10395669
[TBL] [Abstract][Full Text] [Related]
28. Interferons, interferon-like cytokines, and their receptors.
Pestka S; Krause CD; Walter MR
Immunol Rev; 2004 Dec; 202():8-32. PubMed ID: 15546383
[TBL] [Abstract][Full Text] [Related]
29. 125I-labelled human interferons alpha, beta and gamma: comparative receptor-binding data.
Merlin G; Falcoff E; Aguet M
J Gen Virol; 1985 May; 66 ( Pt 5)():1149-52. PubMed ID: 3158718
[TBL] [Abstract][Full Text] [Related]
30. Interferon is a polypeptide hormone.
Faltynek CR; Baglioni C
Microbiol Sci; 1984 Jul; 1(4):81-5. PubMed ID: 6086078
[TBL] [Abstract][Full Text] [Related]
31. Recombinant interferons increase macrophage Fc receptor capacity.
Fertsch D; Vogel SN
J Immunol; 1984 May; 132(5):2436-9. PubMed ID: 6425404
[TBL] [Abstract][Full Text] [Related]
32. Effects of type I interferons on IGF-mediated autocrine/paracrine growth of human neuroendocrine tumor cells.
Vitale G; van Koetsveld PM; de Herder WW; van der Wansem K; Janssen JA; Colao A; Lombardi G; Lamberts SW; Hofland LJ
Am J Physiol Endocrinol Metab; 2009 Mar; 296(3):E559-66. PubMed ID: 19141687
[TBL] [Abstract][Full Text] [Related]
33. Identification of functional type I and type II interferon receptors.
Pestka S
Hokkaido Igaku Zasshi; 1994 Nov; 69(6):1301-19. PubMed ID: 7705745
[TBL] [Abstract][Full Text] [Related]
34. The interferon gamma receptor.
Celada A
Lymphokine Res; 1988; 7(1):61-73. PubMed ID: 2966266
[TBL] [Abstract][Full Text] [Related]
35. Inhibitory effects of alpha-interferon on epidermal growth factor-mediated receptor-dependent events.
Fish EN; Ghislain J; Trogadis J; Stevens JK
Cancer Res; 1993 Nov; 53(21):5148-57. PubMed ID: 7693332
[TBL] [Abstract][Full Text] [Related]
36. Cell surface receptor-mediated internalization of interferon: its relation to the antiviral activity of interferon.
Yonehara S; Ishii A; Yonehara-Takahashi M
J Gen Virol; 1983 Nov; 64 (Pt 11)():2409-18. PubMed ID: 6196440
[TBL] [Abstract][Full Text] [Related]
37. Antiviral activity of CHO-SS cell-derived human omega interferon and other human interferons against HCV RNA replicons and related viruses.
Buckwold VE; Wei J; Huang Z; Huang C; Nalca A; Wells J; Russell J; Collins B; Ptak R; Lang W; Scribner C; Blanchett D; Alessi T; Langecker P
Antiviral Res; 2007 Feb; 73(2):118-25. PubMed ID: 16987555
[TBL] [Abstract][Full Text] [Related]
38. Domains of interaction between alpha interferon and its receptor components.
Uzé G; Di Marco S; Mouchel-Vielh E; Monneron D; Bandu MT; Horisberger MA; Dorques A; Lutfalla G; Mogensen KE
J Mol Biol; 1994 Oct; 243(2):245-57. PubMed ID: 7932753
[TBL] [Abstract][Full Text] [Related]
39. Human type I interferons: structure and function.
Kontsek P
Acta Virol; 1994 Dec; 38(6):345-60. PubMed ID: 7793359
[TBL] [Abstract][Full Text] [Related]
40. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense.
Zhang SY; Boisson-Dupuis S; Chapgier A; Yang K; Bustamante J; Puel A; Picard C; Abel L; Jouanguy E; Casanova JL
Immunol Rev; 2008 Dec; 226():29-40. PubMed ID: 19161414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
